Regions Financial Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.8M | Sell |
10,048
-575
| -5% | -$166K | 0.02% | 319 |
|
|
2025
Q4 | $3.22M | Sell |
10,623
-704
| -6% | -$220K | 0.02% | 305 |
|
|
2025
Q3 | $3.18M | Sell |
11,327
-846
| -7% | -$230K | 0.02% | 304 |
|
|
2025
Q2 | $2.94M | Buy |
12,173
+1,845
| +18% | +$436K | 0.02% | 312 |
|
|
2025
Q1 | $2.52M | Buy |
10,328
+1,787
| +21% | +$538K | 0.02% | 325 |
|
|
2024
Q4 | $2.81M | Sell |
8,541
-321
| -4% | -$109K | 0.02% | 307 |
|
|
2024
Q3 | $2.97M | Buy |
8,862
+50
| +0.6% | +$15.9K | 0.02% | 305 |
|
|
2024
Q2 | $2.41M | Sell |
8,812
-22
| -0.2% | -$6.4K | 0.02% | 337 |
|
|
2024
Q1 | $3.06M | Buy |
8,834
+1,429
| +19% | +$470K | 0.02% | 302 |
|
|
2023
Q4 | $2.39M | Buy |
7,405
+336
| +5% | +$105K | 0.02% | 336 |
|
|
2023
Q3 | $2.53M | Buy |
7,069
+159
| +2% | +$61.3K | 0.02% | 308 |
|
|
2023
Q2 | $2.62M | Buy |
6,910
+2,333
| +51% | +$949K | 0.02% | 316 |
|
|
2023
Q1 | $2.19M | Buy |
4,577
+297
| +7% | +$139K | 0.02% | 328 |
|
|
2022
Q4 | $1.8M | Sell |
4,280
-127
| -3% | -$51.3K | 0.02% | 359 |
|
|
2022
Q3 | $1.84M | Buy |
4,407
+272
| +7% | +$136K | 0.02% | 343 |
|
|
2022
Q2 | $2.05M | Sell |
4,135
-409
| -9% | -$213K | 0.02% | 340 |
|
|
2022
Q1 | $2.56M | Sell |
4,544
-215
| -5% | -$130K | 0.02% | 325 |
|
|
2021
Q4 | $3.6M | Sell |
4,759
-28
| -0.6% | -$21K | 0.03% | 283 |
|
|
2021
Q3 | $3.57M | Buy |
4,787
+207
| +5% | +$155K | 0.03% | 269 |
|
|
2021
Q2 | $2.95M | Sell |
4,580
-179
| -4% | -$109K | 0.03% | 301 |
|
|
2021
Q1 | $2.72M | Buy |
4,759
+30
| +0.6% | +$17.8K | 0.02% | 298 |
|
|
2020
Q4 | $2.76M | Sell |
4,729
-261
| -5% | -$149K | 0.03% | 282 |
|
|
2020
Q3 | $2.57M | Sell |
4,990
-5
| -0.1% | -$2.53K | 0.03% | 272 |
|
|
2020
Q2 | $2.25M | Buy |
4,995
+347
| +7% | +$153K | 0.03% | 283 |
|
|
2020
Q1 | $1.63M | Buy |
4,648
+35
| +0.8% | +$12.9K | 0.02% | 295 |
|
|
2019
Q4 | $1.71M | Buy |
4,613
+457
| +11% | +$161K | 0.02% | 325 |
|
|
2019
Q3 | $1.38M | Sell |
4,156
-9
| -0.2% | -$2.94K | 0.02% | 341 |
|
|
2019
Q2 | $1.3M | Sell |
4,165
-57
| -1% | -$17.1K | 0.01% | 355 |
|
|
2019
Q1 | $1.29M | Buy |
4,222
+261
| +7% | +$70.4K | 0.01% | 359 |
|
|
2018
Q4 | $920K | Buy |
3,961
+290
| +8% | +$77.8K | 0.01% | 404 |
|
|
2018
Q3 | $1.15M | Buy |
3,671
+410
| +13% | +$127K | 0.01% | 403 |
|
|
2018
Q2 | $941K | Buy |
3,261
+258
| +9% | +$71.2K | 0.01% | 428 |
|
|
2018
Q1 | $751K | Buy |
3,003
+154
| +5% | +$39.2K | 0.01% | 469 |
|
|
2017
Q4 | $679K | Sell |
2,849
-11
| -0.4% | -$2.67K | 0.01% | 503 |
|
|
2017
Q3 | $636K | Sell |
2,860
-135
| -5% | -$30.4K | 0.01% | 564 |
|
|
2017
Q2 | $677K | Sell |
2,995
-43
| -1% | -$9.37K | 0.01% | 553 |
|
|
2017
Q1 | $606K | Sell |
3,038
-179
| -6% | -$34.5K | 0.01% | 615 |
|
|
2016
Q4 | $587K | Sell |
3,217
-188
| -6% | -$32.1K | 0.01% | 622 |
|
|
2016
Q3 | $558K | Sell |
3,405
-168
| -5% | -$25.5K | 0.01% | 628 |
|
|
2016
Q2 | $511K | Sell |
3,573
-335
| -9% | -$47.8K | 0.01% | 640 |
|
|
2016
Q1 | $535K | Sell |
3,908
-666
| -15% | -$87.4K | 0.01% | 617 |
|
|
2015
Q4 | $634K | Sell |
4,574
-125
| -3% | -$17.3K | 0.01% | 580 |
|
|
2015
Q3 | $631K | Buy |
4,699
+217
| +5% | +$31.2K | 0.01% | 586 |
|
|
2015
Q2 | $675K | Sell |
4,482
-34
| -0.8% | -$4.86K | 0.01% | 580 |
|
|
2015
Q1 | $611K | Sell |
4,516
-254
| -5% | -$31.5K | 0.01% | 606 |
|
|
2014
Q4 | $575K | Buy |
4,770
+74
| +2% | +$8.52K | 0.01% | 630 |
|
|
2014
Q3 | $533K | Sell |
4,696
-76
| -2% | -$9.01K | 0.01% | 755 |
|
|
2014
Q2 | $571K | Buy |
4,772
+179
| +4% | +$21.9K | 0.01% | 755 |
|
|
2014
Q1 | $589K | Buy |
4,593
+742
| +19% | +$95.1K | 0.01% | 738 |
|
|
2013
Q4 | $477K | Buy |
3,851
+954
| +33% | +$116K | 0.01% | 795 |
|
|
2013
Q3 | $340K | Buy |
2,897
+878
| +43% | +$104K | ﹤0.01% | 852 |
|
|
2013
Q2 | $227K | Buy |
+2,019
| New | +$237K | ﹤0.01% | 977 |
|
Other funds holding BIO
VCM
VPM
AI
